GET THE APP

..

Journal of Molecular Biomarkers & Diagnosis

ISSN: 2155-9929

Open Access

Citations Report

Journal of Molecular Biomarkers & Diagnosis : Citations & Metrics Report

Articles published in Journal of Molecular Biomarkers & Diagnosis have been cited by esteemed scholars and scientists all around the world.

Journal of Molecular Biomarkers & Diagnosis has got h-index 19, which means every article in Journal of Molecular Biomarkers & Diagnosis has got 19 average citations.

Following are the list of articles that have cited the articles published in Journal of Molecular Biomarkers & Diagnosis.

  2022 2021 2020 2019 2018

Year wise published articles

61 64 25 14 37

Year wise citations received

182 206 253 221 222
Journal total citations count 2054
Journal impact factor 2.04
Journal 5 years impact factor 5.42
Journal cite score 5.28
Journal h-index 19
Journal h-index since 2018 14
Important citations

Chockaiyan, Usha, Abirami Sitharanjithan, Kiruthika Lakshmi Parameswaran, and Meenakshi Selvaraj. "Role of Artificial Intelligence in Cancer Nanotheranostics." In Cancer Nanotheranostics, pp. 285-304. Springer, Cham, 2021.

Elberskirch, Linda, Thorsten Knoll, Rebecca Königsmark, Janis Renner, Nadine Wilhelm, Hagen von Briesen, and Sylvia Wagner. "Microfluidic 3D intestine tumor spheroid model for efficient in vitro investigation of nanoparticular formulations." Journal of Drug Delivery Science and Technology 63 (2021): 102496.

Elberskirch, Linda, Thorsten Knoll, Rebecca Königsmark, Janis Renner, Nadine Wilhelm, Hagen von Briesen, and Sylvia Wagner. "Microfluidic 3D intestine tumor spheroid model for efficient in vitro investigation of nanoparticular formulations." Journal of Drug Delivery Science and Technology 63 (2021): 102496.

Bhaumik, Srabani, Jean Boyer, Chaitali Banerjee, Samantha Clark, Noemi Sebastiao, Elizabeth Vela, and Penny Towne. "Fluorescent multiplexing of 3D spheroids: Analysis of biomarkers using automated immunohistochemistry staining platform and multispectral imaging." Journal of Cellular Biochemistry 121, no. 12 (2020): 4974-4990.

MALAKPOUR-PERMLID, A. T. E. N. A. "From a Road Less Travelled to a Worn Path."

Ringquist, Rachel, Delta Ghoshal, Ritika Jain, and Krishnendu Roy. "Understanding and Improving Cellular Immunotherapies Against Cancer: From Cell-Manufacturing to Tumor-Immune Models." Advanced Drug Delivery Reviews (2021): 114003.

Smalley, Munisha, Michelle Przedborski, Saravanan Thiyagarajan, Moriah Pellowe, Amit Verma, Nilesh Brijwani, Debika Datta et al. "Integrating systems biology and an ex vivo human tumor model elucidates PD-1 blockade response dynamics." Iscience 23, no. 6 (2020): 101229.

Yalcin, Gizem Damla, Nurseda Danisik, Rana Can Baygin, and Ahmet Acar. "Systems Biology and Experimental Model Systems of Cancer." Journal of Personalized Medicine 10, no. 4 (2020): 180.

Takheaw, Nuchjira, Gunya Sittithumcharee, Ryusho Kariya, Watchara Kasinrerk, and Seiji Okada. "Anti-human CD99 antibody exerts potent antitumor effects in mantle cell lymphoma." Cancer Immunology, Immunotherapy 70, no. 6 (2021): 1557-1567.

Sapio, Luigi, Alessia Salzillo, Angela Ragone, Michela Illiano, Annamaria Spina, and Silvio Naviglio. "Targeting CREB in cancer therapy: A key candidate or one of many? An update." Cancers 12, no. 11 (2020): 3166.

Caetano-Pinto, Pedro, and Simone H. Stahl. "Perspective on the application of microphysiological systems to drug transporter studies." Drug Metabolism and Disposition 46, no. 11 (2018): 1647-1657.

Stulpinas, Aurimas, Aušra Imbrasait?, Natalija Krestnikova, and Audron? Valerija Kalvelyt?. "Recent approaches encompassing the phenotypic cell heterogeneity for anticancer drug efficacy evaluation." Tumor Progression and Metastasis (2019): 1-47.

Boucherit, Nicolas, Laurent Gorvel, and Daniel Olive. "3D tumor models and their use for the testing of immunotherapies." Frontiers in Immunology 11 (2020): 3220.

Rampasek, Ladislav. "Latent-variable models for drug response prediction and genetic testing." PhD diss., University of Toronto (Canada), 2020.

Xin, Xin, Yongqi Wu, Ru Zang, and Shang-Tian Yang. "A fluorescent 3D cell culture assay for high throughput screening of cancer drugs down-regulating survivin." Journal of biotechnology 289 (2019): 80-87.

Wojcicki, Anna V., Meena Kadapakkam, Adam Frymoyer, Norman Lacayo, Hee-Don Chae, and Kathleen M. Sakamoto. "Repurposing Drugs for Acute Myeloid Leukemia: A Worthy Cause or a Futile Pursuit?." Cancers 12, no. 2 (2020): 441.

Craig, Morgan, Adrianne L. Jenner, Bumseok Namgung, Luke P. Lee, and Aaron Goldman. "Engineering in medicine to address the challenge of cancer drug resistance: from micro-and nanotechnologies to computational and mathematical modeling." Chemical Reviews 121, no. 6 (2020): 3352-3389.

Salmanpour, Mohsen, Gholamhossein Yousefi, Soliman Mohammadi Samani, Samaneh Mohammadi, Mohammad Hossein Anbardar, and Alimohammad Tamaddon. "Nanoparticulate delivery of irinotecan active metabolite (SN38) in murine colorectal carcinoma through conjugation to poly (2-ethyl 2-oxazoline)-b-poly (L-glutamic acid) double hydrophilic copolymer." European Journal of Pharmaceutical Sciences 136 (2019): 104941.

Hamilton, Gerhard, and Barbara Rath. "Applicability of tumor spheroids for in vitro chemosensitivity assays." Expert opinion on drug metabolism & toxicology 15, no. 1 (2019): 15-23.

Arroyo?Crespo, Juan J., Ana Armiñán, David Charbonnier, Coralie Deladriere, Martina Palomino?Schätzlein, Rubén Lamas?Domingo, Jerónimo Forteza, Antonio Pineda?Lucena, and María J. Vicent. "Characterization of triple?negative breast cancer preclinical models provides functional evidence of metastatic progression." International journal of cancer 145, no. 8 (2019): 2267-2281.

Relevant Topics

Google Scholar citation report
Citations: 2054

Journal of Molecular Biomarkers & Diagnosis received 2054 citations as per Google Scholar report

Journal of Molecular Biomarkers & Diagnosis peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward